49 Matching Annotations
  1. Last 7 days
  2. Aug 2022
    1. Chadeau-Hyam, M., Wang, H., Eales, O., Haw, D., Bodinier, B., Whitaker, M., Walters, C. E., Ainslie, K. E. C., Atchison, C., Fronterre, C., Diggle, P. J., Page, A. J., Trotter, A. J., Ashby, D., Barclay, W., Taylor, G., Cooke, G., Ward, H., Darzi, A., … Elliott, P. (2022). SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): A series of cross-sectional random community surveys. The Lancet Respiratory Medicine, 0(0). https://doi.org/10.1016/S2213-2600(21)00542-7

  3. Mar 2022
  4. Feb 2022
    1. Dr Emma Hodcroft. (2022, January 28). Just to clarify some confusion about what “Omicron” is. “Omicron” has always applied to the whole family (BA.1-3—We’ve known about them all since late-Nov/early-Dec). But the prevalence of BA.1 meant that it got shorthanded as ’Omicron’—That’s causing some confusion now!🥴 https://t.co/M4FwzGbluo [Tweet]. @firefoxx66. https://twitter.com/firefoxx66/status/1486999566725656576

    1. Deepti Gurdasani. (2022, January 29). Going to say this again because it’s important. Case-control studies to determine prevalence of long COVID are completely flawed science, but are often presented as being scientifically robust. This is not how we can define clinical syndromes or their prevalence! A thread. [Tweet]. @dgurdasani1. https://twitter.com/dgurdasani1/status/1487366920508694529

    1. Deepti Gurdasani. (2022, January 30). Have tried to now visually illustrate an earlier thread I wrote about why prevalence estimates based on comparisons of “any symptom” between infected cases, and matched controls will yield underestimates for long COVID. I’ve done a toy example below here, to show this 🧵 [Tweet]. @dgurdasani1. https://twitter.com/dgurdasani1/status/1487578265187405828

  5. Jan 2022
  6. Dec 2021
  7. Oct 2021
  8. Aug 2021
  9. Jul 2021
  10. Jun 2021
  11. May 2021
  12. Apr 2021
  13. Mar 2021
  14. Feb 2021
    1. Carl T. Bergstrom. (2021, January 31). A somewhat technical thread about measuring vaccine efficacy. We’re used to the notion that certain properties of tests for disease depend on prevalence: Positive and negative predictive value do, for example, whereas sensitivity and specificity do not. [Tweet]. @CT_Bergstrom. https://twitter.com/CT_Bergstrom/status/1355762090078703621

  15. Jan 2021
  16. Sep 2020
  17. Aug 2020
  18. Jul 2020
    1. Pollán, M., Pérez-Gómez, B., Pastor-Barriuso, R., Oteo, J., Hernán, M. A., Pérez-Olmeda, M., Sanmartín, J. L., Fernández-García, A., Cruz, I., Larrea, N. F. de, Molina, M., Rodríguez-Cabrera, F., Martín, M., Merino-Amador, P., Paniagua, J. L., Muñoz-Montalvo, J. F., Blanco, F., Yotti, R., Blanco, F., … Villa, A. V. de la. (2020). Prevalence of SARS-CoV-2 in Spain (ENE-COVID): A nationwide, population-based seroepidemiological study. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(20)31483-5

  19. Jun 2020
  20. May 2020
  21. Sep 2019
    1. Variation in Rates of Fatal Police Shootings across US States:the Role of Firearm Availability

      Hello! This article is about the relationship between firearm prevalence (the IV) and the rates of fatal police shootings (the DV). The authors hypothesize that the greater the prevalence of firearms, the grater the rates of fatal police shooting.

      This article follows the classical structure of social science research -- abstract, introduction, literature review/theory, research design, findings, and conclusions.

  22. Jan 2019
  23. Aug 2016